Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Mark

Showing results (161-170 of 331) with videos related to

Pageof 34
Sort By:
Circulation. Cardiovascular Quality and Outcomes|May 17, 2017
Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)Yashashwi Pokharel, Khaja Chinnakondepalli, Katherine Vilain, et al.
Circulation|September 26, 2012
Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart AssociationSandra B Dunbar, Cynthia M Dougherty, Samuel F Sears, et al.
Heart Rhythm|June 23, 2015
SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac deathWan-Tai M Au-Yeung, Per G Reinhall, Jeanne E Poole, et al.
Critical Care Medicine|December 24, 2009
Evolution of the coronary care unit: clinical characteristics and temporal trends in healthcare delivery and outcomesJason N Katz, Bimal R Shah, Elizabeth M Volz, et al.
Journal of the American Society of Nephrology : JASN|August 26, 2003
Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery diseaseDonal N Reddan, Lynda Anne Szczech, Robert H Tuttle, et al.
Circulation|December 22, 2021
Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results From the CABANA TrialTristram D Bahnson, Anna Giczewska, Daniel B Mark, et al.
Circulation|September 6, 2023
Cost-Effectiveness of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: The VICTORIA Randomized Clinical TrialDerek S Chew, Yanhong Li, Robert Bigelow, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 31, 2022
Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANAKristi H Monahan, T Jared Bunch, Daniel B Mark, et al.
Journal of the American College of Cardiology|February 10, 2015
Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO studyPatricia A Cowper, Wenqin Pan, Kevin J Anstrom, et al.
Journal of the American College of Cardiology|June 27, 2020
Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA TrialJeanne E Poole, Tristram D Bahnson, Kristi H Monahan, et al.
Pageof 34

Showing results (161-170 of 331) with videos related to

Sort By:
Pageof 34
Circulation. Cardiovascular Quality and Outcomes|May 17, 2017
Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome: Results From the IMPROVE-IT Trial (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)Yashashwi Pokharel, Khaja Chinnakondepalli, Katherine Vilain, et al.
Circulation|September 26, 2012
Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart AssociationSandra B Dunbar, Cynthia M Dougherty, Samuel F Sears, et al.
Heart Rhythm|June 23, 2015
SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac deathWan-Tai M Au-Yeung, Per G Reinhall, Jeanne E Poole, et al.
Critical Care Medicine|December 24, 2009
Evolution of the coronary care unit: clinical characteristics and temporal trends in healthcare delivery and outcomesJason N Katz, Bimal R Shah, Elizabeth M Volz, et al.
Journal of the American Society of Nephrology : JASN|August 26, 2003
Chronic kidney disease, mortality, and treatment strategies among patients with clinically significant coronary artery diseaseDonal N Reddan, Lynda Anne Szczech, Robert H Tuttle, et al.
Circulation|December 22, 2021
Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results From the CABANA TrialTristram D Bahnson, Anna Giczewska, Daniel B Mark, et al.
Circulation|September 6, 2023
Cost-Effectiveness of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: The VICTORIA Randomized Clinical TrialDerek S Chew, Yanhong Li, Robert Bigelow, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 31, 2022
Influence of atrial fibrillation type on outcomes of ablation vs. drug therapy: results from CABANAKristi H Monahan, T Jared Bunch, Daniel B Mark, et al.
Journal of the American College of Cardiology|February 10, 2015
Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO studyPatricia A Cowper, Wenqin Pan, Kevin J Anstrom, et al.
Journal of the American College of Cardiology|June 27, 2020
Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA TrialJeanne E Poole, Tristram D Bahnson, Kristi H Monahan, et al.
Pageof 34